Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Very fast paced, challenging but rewarding
O que faz você mais feliz no trabalho?
Interacting with my coworkers and driving performance
Quais são algumas das melhores coisas da sua equipe?
Creative, dedicated and with a sense of urgency
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
The people and level of commitment
O que você mais gosta nos lideres?
Passion, sense of urgency putting patients first!
Qual é a melhor parte das suas compensações?
Base salary, equity and bonus
Other Employee Reviews for Karyopharm Therapeutics
×